Cargando…

Heterogeneity of Acetylcholine Receptor Autoantibody–Mediated Complement Activity in Patients With Myasthenia Gravis

BACKGROUND AND OBJECTIVES: Autoantibodies targeting the acetylcholine receptor (AChR), found in patients with myasthenia gravis (MG), mediate pathology through 3 mechanisms: complement-directed tissue damage, blocking of the acetylcholine binding site, and internalization of the AChR. Clinical assay...

Descripción completa

Detalles Bibliográficos
Autores principales:	Obaid, Abeer H., Zografou, Chryssa, Vadysirisack, Douangsone D., Munro-Sheldon, Bailey, Fichtner, Miriam L., Roy, Bhaskar, Philbrick, William M., Bennett, Jeffrey L., Nowak, Richard J., O'Connor, Kevin C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128035/ https://www.ncbi.nlm.nih.gov/pubmed/35473886 http://dx.doi.org/10.1212/NXI.0000000000001169

Ejemplares similares

Myasthenia gravis complement activity is independent of autoantibody titer and disease severity
por: Fichtner, Miriam L., et al.
Publicado: (2022)

Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features
por: Park, Kee Hong, et al.
Publicado: (2018)

Role of complement in myasthenia gravis
por: San, Pyae Phyo, et al.
Publicado: (2023)

Affinity maturation is required for pathogenic monovalent IgG4 autoantibody development in myasthenia gravis
por: Fichtner, Miriam L., et al.
Publicado: (2020)

Autoantibodies to Agrin in Myasthenia Gravis Patients
por: Zhang, Bin, et al.
Publicado: (2014)

Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients
por: Takata, Kazushiro, et al.
Publicado: (2019)

Correction: Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features
por: Park, Kee Hong, et al.
Publicado: (2018)

Complement Inhibitor Therapy for Myasthenia Gravis
por: Albazli, Khaled, et al.
Publicado: (2020)

Complement Inhibition for the Treatment of Myasthenia Gravis
por: Mantegazza, Renato, et al.
Publicado: (2020)

Autoantibodies in Japanese patients with ocular myasthenia gravis
por: Nagaishi, Akiko, et al.
Publicado: (2020)

Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology
por: Fichtner, Miriam L., et al.
Publicado: (2020)

Reemergence of pathogenic, autoantibody-producing B cell clones in myasthenia gravis following B cell depletion therapy
por: Fichtner, Miriam L., et al.
Publicado: (2022)

Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture
por: Koneczny, Inga, et al.
Publicado: (2019)

Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management
por: Lazaridis, Konstantinos, et al.
Publicado: (2020)

IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis(†)
por: Leite, Maria Isabel, et al.
Publicado: (2008)

The Anti-Acetylcholine Receptor Antibody Test in Suspected Ocular Myasthenia Gravis
por: Lee, Jung Jin, et al.
Publicado: (2014)

Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis
Publicado: (1978)

Complement deposition at the neuromuscular junction in seronegative myasthenia gravis
por: Hoffmann, Sarah, et al.
Publicado: (2020)

Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics
por: Lazaridis, Konstantinos, et al.
Publicado: (2020)

Remission of severe myasthenia gravis after autologous stem cell transplantation
por: Schlatter, Monica I., et al.
Publicado: (2023)

Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies
Publicado: (1976)

Repeated Acetylcholine Receptor Antibody-Concentrations and Association to Clinical Myasthenia Gravis Development
por: Heldal, Anne Taraldsen, et al.
Publicado: (2014)

Prominent T-Cell Responses against the Acetylcholine Receptor ε Subunit in Myasthenia Gravis
por: Neuhaus, Oliver, et al.
Publicado: (2019)

Brainstem Encephalitis With Low-Titer Acetylcholine Receptor Antibodies Mimicking Myasthenia Gravis
por: Ayzenberg, Ilya, et al.
Publicado: (2019)

Human Neutrophils Respond to Complement Activation and Inhibition in Microfluidic Devices
por: Muldur, Sinan, et al.
Publicado: (2021)

Complement Activation Profile in Myasthenia Gravis Patients: Perspectives for Tailoring Anti-Complement Therapy
por: Iacomino, Nicola, et al.
Publicado: (2022)

Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007)

Myasthenia Gravis
por: Aarli, Johan A., et al.
Publicado: (2011)

Myasthenia Gravis
Publicado: (1905)

Myasthenia Gravis
por: Wilson, Andrew
Publicado: (1952)

Myasthenia Gravis
por: Bramwell, Edwin
Publicado: (1901)

Pathogenetic Significance of Fetal-Type Acetylcholine Receptors on Thymic Myoid Cells in Myasthenia Gravis
por: Geuder, Kerstin I., et al.
Publicado: (1992)

Possible implications of dysregulated nicotinic acetylcholine receptor diffusion and nanocluster formation in myasthenia gravis
por: Barrantes, Francisco J.
Publicado: (2020)

The association between anti‐acetylcholine receptor antibody level and clinical improvement in myasthenia gravis
por: Marcuse, Florit, et al.
Publicado: (2022)

MuSK-Myasthenia Gravis Unmasked by Hydroxychloroquine
por: Bhaskar, Shalini, et al.
Publicado: (2022)

Electronic health record derived-impact of COVID-19 on myasthenia gravis
por: Roy, Bhaskar, et al.
Publicado: (2021)

Summary of Research: Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis
por: Vu, Tuan, et al.
Publicado: (2023)

MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity
por: Yandamuri, Soumya S., et al.
Publicado: (2023)

Analysis of peripheral B cells and autoantibodies against the anti-nicotinic acetylcholine receptor derived from patients with myasthenia gravis using single-cell manipulation tools
por: Makino, Tomohiro, et al.
Publicado: (2017)

A Striational Muscle Antigen and Myasthenia Gravis-Associated Thymomas Share an Acetylcholine-Receptor Epitope
por: Marx, Alexander, et al.
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_sm4d97nqj56b001mq7bvg2npuk